KORE POTASH PLC — Director's Dealing 2018

Aug 7, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0386X

Kore Potash PLC

07 August 2018

Kore Potash Plc

("Kore Potash" or the "Company")

DIRECTOR/PDMR SHAREHOLDING

Kore Potash, the potash exploration and development company whose flagship asset is the Kola Project ("Kola" or the "Project"), located within the Company's 97%-owned Sintoukola Potash Project in the Republic of Congo, has received notice of the below.

Following shareholder approval at the AGM held on 27 June 2018, the US$250,000 convertible loan note agreement dated 26 March 2018 between Theseus (Guernsey) Limited as trustee of the Barland Trust (the "Trust") (of which David Hathorn is a beneficiary) ("Convertible Loan Note") has converted to 1,618,250 new ordinary shares.  In accordance with the Convertible Loan Note agreement, the Trust will also receive 250,000 equity warrants on the basis of one equity warrant for each US$1 of principal amount converted.

Application has been made for the 1,618,250 new ordinary shares to be admitted to trading on AIM at 8 a.m. on 10 August 2018 ("Admission").  The new ordinary shares will rank pari passu with the existing ordinary shares in issue.

From Admission, the Company's issued ordinary shares will comprise 860,852,693 ordinary shares of US$0.001 each.  No ordinary shares are held in treasury.  The figure of 860,852,693 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Notification of transaction by Person Discharging Managerial Responsibilities ("PDMR")

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	David Hathorn
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Kore Potash Plc
b)	LEI	213800NWX7EHG4UVC107
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of US$0.001 each
	Identification code	GB00BYP2QJ94
b)	Nature of the transaction	Conversion of convertible loan note
c)	Price(s) and volume(s)	Price: A$0.20 Volume:  1,618,250
d)	Aggregated information	Aggregated volume: 1,618,250 Price: A$0.20
e)	Date of the transaction	27 June 2018
f)	Place of the transaction	Outside of a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	David Hathorn
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Kore Potash Plc
b)	LEI	213800NWX7EHG4UVC107
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Equity warrants to subscribe for new ordinary shares of US$0.001 each
	Identification code	GB00BYP2QJ94
b)	Nature of the transaction	Issue of equity warrants
c)	Price(s) and volume(s)	Price: A$0.30 Volume:  250,000
d)	Aggregated information	Aggregated volume: 250,000 Price: A$0.30
e)	Date of the transaction	27 June 2018
f)	Place of the transaction	Outside of a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHLIFSDTLIDIIT